相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monoclonal antibodies to fetal bovine serum acetylcholinesterase distinguish between acetylcholinesterases from ruminant and non-ruminant species
Ramachandra S. Naik et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Purification of human butyrylcholinesterase from frozen Cohn fraction IV-4 by ion exchange and Hupresin affinity chromatography
Lawrence M. Schopfer et al.
PLOS ONE (2019)
Production of pharmaceutical proteins by transgenic animals
L-M. Houdebine
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2018)
FDA approves 'farmaceutical' drug from transgenic chickens
Cormac Sheridan
NATURE BIOTECHNOLOGY (2016)
The transgenic animal platform for biopharmaceutical production
L. R. Bertolini et al.
TRANSGENIC RESEARCH (2016)
Comparison of 5 monoclonal antibodies for immunopurification of human butyrylcholinesterase on Dynabeads: KD values, binding pairs, and amino acid sequences
Hong Peng et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model
Yvonne J. Rosenberg et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase
Brian C. Geyer et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
Pilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity
Ashima Saxena et al.
PROCESS BIOCHEMISTRY (2010)
European Community and US-FDA Approval of Recombinant Human Antithrombin Produced in Genetically Altered Goats
Cafer Adiguzel et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
First US approval for a transgenic animal drug
Jim Kling
NATURE BIOTECHNOLOGY (2009)
Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid In Human Tissues and Biotherapeutic Products
Sandra L. Diaz et al.
PLOS ONE (2009)
Comparison of methods used for the determination of cholinesterase activity in whole blood
Ramachandra S. Naik et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Advantages of the WRAIR whole blood cholinesterase assay: Comparative analysis to the micro-Ellman, Test-mate ChE™ and Michel (ΔpH) assays
Julian R. Haigh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Glycoproteomic characterization of butyrylcholinesterase from human plasma
Daniel Kolarich et al.
PROTEOMICS (2008)
A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice
Nageswararao Chilukuri et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning
Yue-Jin Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bioscavenger for protection from toxicity of organophosphorus compounds
Ashima Saxena et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits
K Koles et al.
GLYCOBIOLOGY (2004)
Application of transgenesis in livestock for agriculture and biomedicine
H Niemann et al.
ANIMAL REPRODUCTION SCIENCE (2003)
Making recombinant proteins in animals - different systems, different applications
MK Dyck et al.
TRENDS IN BIOTECHNOLOGY (2003)
Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity
EG Duysen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
N-glycolylneuraminic acid deficiency in humans
A Varki
BIOCHIMIE (2001)
Transgenic animal bioreactors
LM Houdebine
TRANSGENIC RESEARCH (2000)
分享论文
